Form 4: Director Marillyn Hewson Increases JNJ Equity Stake
Statement of Changes in Beneficial Ownership
Johnson & Johnson Director Marillyn A. Hewson acquired 214.786 deferred share units as part of the company's director compensation plan.
Summary
- Director Marillyn A. Hewson acquired 214.786 Deferred Share Units (DSUs) on June 9, 2026.
- The acquisition was made at a price of $232.79 per unit.
- The transaction represents a deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors.
- Following this transaction, the reporting person holds a total of 15,791.877 units.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation that does not impact the company's operational or financial outlook.
Positives
- Demonstrates continued alignment of director interests with shareholders through equity-linked compensation.
Negatives
- None identified; this is a routine administrative transaction related to director compensation.
Risks
- None identified; this is a standard regulatory filing for director compensation.
Future Outlook
The Deferred Share Units are to be settled in cash upon the termination of the reporting person's directorship, reflecting a long-term holding strategy.
Industry Context
StockSavvy.ai notes that routine director equity acquisitions via deferred fee plans are standard corporate governance practices among large-cap pharmaceutical companies, signaling stable board oversight.
Comparison to Industry Standards
- The transaction aligns with standard executive and director compensation practices observed in S&P 500 companies.
- The use of Deferred Share Units is a common mechanism to ensure director retention and long-term alignment with company performance.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Director Compensation | Deferral of cash retainer into Deferred Share Units under the Amended and Restated Deferred Fee Plan. | 06/09/2026 | Neutral; standard practice for director compensation. |
Stakeholder Impact
- Minimal impact on shareholders as this is a standard compensation-related transaction.
Next Steps
- The reporting person will continue to hold the units until the termination of their directorship.
Key Dates
| Date | Description |
|---|---|
| 06/09/2026 | Date of the earliest transaction involving the acquisition of Deferred Share Units. |
| 06/11/2026 | Date the Form 4 was signed and filed with the SEC. |
Keywords
Johnson & Johnson, JNJ, Form 4, Director Compensation, Insider Transaction, Deferred Share Units
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.